In GBM patients, PD-1, LAG-3, TIGIT, and CD39 were found highly expressed on CD8+ TILs (23), supporting the reason to deeply investigate the interplay between PD-1 receptor and its ligand PD-L1 in CNS tumors. This evidence concerns the gene CD8A and glioblastoma.